4//SEC Filing
Reitan Colleen F 4
Accession 0001735276-25-000097
CIK 0001178670other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:05 PM ET
Size
35.7 KB
Accession
0001735276-25-000097
Insider Transaction Report
Form 4
Reitan Colleen F
Director
Transactions
- Sale
Common Stock
2025-09-09$480.98/sh−25$12,025→ 775 total - Sale
Common Stock
2025-09-09$461.92/sh−2,290$1,057,797→ 11,076 total - Exercise/Conversion
Common Stock
2025-09-09$100.65/sh+18,000$1,811,700→ 18,775 total - Sale
Common Stock
2025-09-09$471.25/sh−222$104,618→ 8,403 total - Sale
Common Stock
2025-09-09$472.82/sh−823$389,131→ 7,580 total - Sale
Common Stock
2025-09-09$479.55/sh−1,386$664,656→ 800 total - Sale
Common Stock
2025-09-09$457.44/sh−1,645$752,489→ 17,130 total - Sale
Common Stock
2025-09-09$458.86/sh−1,888$866,328→ 15,242 total - Sale
Common Stock
2025-09-09$459.73/sh−1,403$645,001→ 13,839 total - Sale
Common Stock
2025-09-09$460.71/sh−473$217,916→ 13,366 total - Sale
Common Stock
2025-09-09$464.36/sh−799$371,024→ 8,625 total - Sale
Common Stock
2025-09-09$477.47/sh−1,183$564,847→ 3,636 total - Exercise/Conversion
Stock Option (right to buy)
2025-09-09−18,000→ 0 totalExercise: $100.65Exp: 2028-06-01→ Common Stock (18,000 underlying) - Sale
Common Stock
2025-09-09$474.22/sh−838$397,396→ 6,742 total - Sale
Common Stock
2025-09-09$474.85/sh−951$451,582→ 5,791 total - Sale
Common Stock
2025-09-09$463.00/sh−1,652$764,876→ 9,424 total - Sale
Common Stock
2025-09-09$476.31/sh−972$462,973→ 4,819 total - Sale
Common Stock
2025-09-09$478.67/sh−1,450$694,072→ 2,186 total
Footnotes (17)
- [F1]This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025.
- [F10]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $472.37 to $473.30. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F11]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $473.48 to $474.48. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F12]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $474.58 to $475.06. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F13]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $475.85 to $476.79. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F14]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $477.05 to $477.88. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F15]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $478.33 to $479.30. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F16]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $479.35 to $479.90. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F17]This stock option was fully vested and exercisable as of June 1, 2021.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $456.93 to $457.91. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $458.22 to $459.09. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $459.29 to $460.22. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F5]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $460.35 to $461.26. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F6]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $461.42 to $462.41. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F7]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $462.73 to $463.52. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F8]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $464.18 to $464.96. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F9]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $470.77 to $471.75. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeother
Related Parties
1- filerCIK 0001740730
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 4:05 PM ET
- Size
- 35.7 KB